Abingdon Health Plc (LON:ABDX – Get Rating)’s stock price was down 4.7% on Wednesday . The stock traded as low as GBX 5.01 ($0.06) and last traded at GBX 5.01 ($0.06). Approximately 73,317 shares were traded during trading, a decline of 76% from the average daily volume of 305,533 shares. The stock had previously closed at GBX 5.25 ($0.06).
Abingdon Health Price Performance
The company has a current ratio of 2.06, a quick ratio of 1.96 and a debt-to-equity ratio of 19.90. The firm has a market cap of £6.09 million, a P/E ratio of -71.50 and a beta of 0.16. The company has a fifty day moving average price of GBX 5.20 and a two-hundred day moving average price of GBX 5.70.
About Abingdon Health
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices worldwide. The company offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; PCRD and PCRD FLEX, nucleic acid lateral flow tests used for rapid readouts post isothermal amplification; Abingdon Simply Test, a range of self-tests; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2.
- Meta Platforms: Efficiency Gains Momentum, Stock Accelerates
- Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock
- SentinelOne: Reversal In-Play For Cybersecurity Stocks
- Is Sportradar Group A Growth Stock To Bet On In 2023?
- Strong Guidance says Boeing is Ready for Takeoff
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.